These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7680608)

  • 1. Ion channel formation by zervamicin-IIB. A molecular modelling study.
    Sansom MS; Balaram P; Karle IL
    Eur Biophys J; 1993; 21(6):369-83. PubMed ID: 7680608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The properties of ion channels formed by zervamicins.
    Balaram P; Krishna K; Sukumar M; Mellor IR; Sansom MS
    Eur Biophys J; 1992; 21(2):117-28. PubMed ID: 1382967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion channels formed by amphipathic helical peptides. A molecular modelling study.
    Sansom MS; Kerr ID; Mellor IR
    Eur Biophys J; 1991; 20(4):229-40. PubMed ID: 1725513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial structure of zervamicin IIB bound to DPC micelles: implications for voltage-gating.
    Shenkarev ZO; Balashova TA; Efremov RG; Yakimenko ZA; Ovchinnikova TV; Raap J; Arseniev AS
    Biophys J; 2002 Feb; 82(2):762-71. PubMed ID: 11806918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptaibol zervamicin IIb structure and dynamics refinement from transhydrogen bond J couplings.
    Shenkarev ZO; Balashova TA; Yakimenko ZA; Ovchinnikova TV; Arseniev AS
    Biophys J; 2004 Jun; 86(6):3687-99. PubMed ID: 15189865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backbone dynamics of the channel-forming antibiotic zervamicin IIB studied by 15N NMR relaxation.
    Korzhnev DM; Bocharov EV; Zhuravlyova AV; Orekhov VY; Ovchinnikova TV; Billeter M; Arseniev AS
    FEBS Lett; 2001 Apr; 495(1-2):52-5. PubMed ID: 11322946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alamethicin and related peptaibols--model ion channels.
    Sansom MS
    Eur Biophys J; 1993; 22(2):105-24. PubMed ID: 7689461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High stability of the hinge region in the membrane-active peptide helix of zervamicin: paramagnetic relaxation enhancement studies.
    Shenkarev ZO; Paramonov AS; Balashova TA; Yakimenko ZA; Baru MB; Mustaeva LG; Raap J; Ovchinnikova TV; Arseniev AS
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1099-105. PubMed ID: 15541401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptaibol antiamoebin I: spatial structure, backbone dynamics, interaction with bicelles and lipid-protein nanodiscs, and pore formation in context of barrel-stave model.
    Shenkarev ZO; Paramonov AS; Lyukmanova EN; Gizatullina AK; Zhuravleva AV; Tagaev AA; Yakimenko ZA; Telezhinskaya IN; Kirpichnikov MP; Ovchinnikova TV; Arseniev AS
    Chem Biodivers; 2013 May; 10(5):838-63. PubMed ID: 23681729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of [Leu1]zervamicin, a membrane ion-channel peptide: implications for gating mechanisms.
    Karle IL; Flippen-Anderson JL; Agarwalla S; Balaram P
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5307-11. PubMed ID: 1711227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR structure of the channel-former zervamicin IIB in isotropic solvents.
    Balashova TA; Shenkarev ZO; Tagaev AA; Ovchinnikova TV; Raap J; Arseniev AS
    FEBS Lett; 2000 Jan; 466(2-3):333-6. PubMed ID: 10682854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the secondary structures of the peptaibols antiamoebin I and zervamicin II modified with D-amino acids and proline analogues.
    Castro TG; Micaêlo NM; Melle-Franco M
    J Mol Model; 2017 Oct; 23(11):313. PubMed ID: 29035420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zervamicins, a structurally characterised peptide model for membrane ion channels.
    Agarwalla S; Mellor IR; Sansom MS; Karle IL; Flippen-Anderson JL; Uma K; Krishna K; Sukumar M; Balaram P
    Biochem Biophys Res Commun; 1992 Jul; 186(1):8-15. PubMed ID: 1378732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the channel-forming polypeptide antiamoebin in a membrane-mimetic environment.
    Karle IL; Perozzo MA; Mishra VK; Balaram P
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5501-4. PubMed ID: 9576911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis of zervamicin IIB and its deuterium-labelled analogues.
    Ogrel A; Bloemhoff W; Lugtenburg J; Raap J
    J Pept Sci; 1997; 3(3):193-208. PubMed ID: 9230485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation of the flexible bent helix of Leu1-zervamicin in crystal C and a possible gating action for ion passage.
    Karle IL; Flippen-Anderson JL; Agarwalla S; Balaram P
    Biopolymers; 1994 Jun; 34(6):721-35. PubMed ID: 8025219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophilic surface maps of channel-forming peptides: analysis of amphipathic helices.
    Kerr ID; Sansom MS
    Eur Biophys J; 1993; 22(4):269-77. PubMed ID: 7504619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Pro/Hyp-kinks in determining the transmembrane helix length and gating mechanism of a [Leu]zervamicin channel.
    Ballesteros JA; Weinstein H
    Biophys J; 1992 Apr; 62(1):110-1. PubMed ID: 1376162
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of zervamicin IIB with lipid bilayers. Molecular dynamics study.
    Levtsova OV; Antonov MY; Naumenkova TV; Sokolova OS
    Comput Biol Chem; 2011 Feb; 35(1):34-9. PubMed ID: 21310660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of serine and threonine sidechains in ion channels: a modelling study.
    Sansom MS
    Eur Biophys J; 1992; 21(4):281-98. PubMed ID: 1385107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.